NEWS
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units
Cosmos Health (NASDAQ:COSM) announced that its subsidiary, Cana Laboratories, has secured additional contract manufacturing agreements with Provident Pharmaceuticals. The new orders include:
408,000 units of MIOREL for muscle spasms
222,000 units of CALCIFOLIN for nucleic acid synthesis
72,000 units of DEXA-DOSE for anti-inflammatory purposes
These orders, combined with a previously announced contract for 4.32 million units of DE3-SOLE, bring the total order book with Provident to 5.02 million units. CEO Greg Siokas expressed enthusiasm for scaling up Cana's contract manufacturing division, anticipating stable, high-margin cash flows for Cosmos Health.
408,000 units of MIOREL for muscle spasms
222,000 units of CALCIFOLIN for nucleic acid synthesis
72,000 units of DEXA-DOSE for anti-inflammatory purposes
These orders, combined with a previously announced contract for 4.32 million units of DE3-SOLE, bring the total order book with Provident to 5.02 million units. CEO Greg Siokas expressed enthusiasm for scaling up Cana's contract manufacturing division, anticipating stable, high-margin cash flows for Cosmos Health.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1066Followers
68Following
7340Visitors
Follow